Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Preclinical study results explain why TMK-688 does not induce drowsiness

Nov. 4, 1998

Otsuka NO inhibitor series particularly useful in asthma and atopic dermatitis

Nov. 4, 1998

Inflazyme advances development of asthma therapeutic

Nov. 4, 1998

Astra's new antiasthmatic, antirhinitic agents

Oct. 29, 1998

Latest preclinical data further supports antiasthmatic efficacy of betotastine besilate

Oct. 28, 1998

New antiasthmatic agent launched in Italy by Zeneca, Chiesi and Recordati

Oct. 27, 1998

FDA grants fast track status to Surfaxin in MAS

Oct. 26, 1998

Fournier characterizes potent and selective human bradykinin B2 antagonist in vitro

Oct. 23, 1998

Antiallergic/antiinflammatory compounds in development at Nikken Chemicals

Oct. 21, 1998

Phase II trial of tgAAV-CF completed, preliminary data presented at CF conference

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...